FDA Device Intelligence
Home › MICHELSON DIAGNOSTICS LTD › VivoSight

VivoSight

MICHELSON DIAGNOSTICS LTD · Model VivoSight Dx · UDI-DI 05060507260012

NQQ Prescription
1
510(k) clearances
69
Adverse events
3
Recalls
27
Facilities

Description

The VivoSight Dx is indicated for use in the two-dimensional, cross-sectional, real-time imaging of external tissues of the human body. This indicated use allows imaging of tissue microstructure including skin, and enables detection and display of regions within the scanned area that are in motion (Dynamic OCT) to aid trained and competent clinicians in their assessment of a patient's clinical conditions.

Recalls

DateFirmReason
2018-04-11Ninepoint Medical Inc.Distal tips of the probes may detach from the probe shaft during use.
2011-12-22Imalux CorporationDuring an FDA inspection, the firm was notified that the wrong tubing was used during the manufacture of the probe for the unit.
2010-07-20Optovue Inc.Use of the CAM attachment may result in a positioning anomaly and mistreatment in the eyes of the patient.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.